Related Experiment Video
Updated: May 14, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
A review of psychosocial issues in patients with chronic hepatitis B
Amirhossein Modabbernia1, Mandana Ashrafi, Reza Malekzadeh
1Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Insights
Chronic hepatitis B (CHBV) significantly impacts patients' health-related quality of life (HRQOL) and mental well-being. Interventions and psycho-education can improve HRQOL, while more research is needed on stigma and coping strategies.
Area of Science:
- Hepatology
- Psychiatry
- Public Health
Background:
- Psychosocial issues and health-related quality of life (HRQOL) are crucial in managing chronic hepatitis B (CHBV).
- Understanding these factors is essential for comprehensive patient care.
Purpose of the Study:
- To review and categorize existing literature on HRQOL, mental health, and psychosocial issues in CHBV patients.
- To identify gaps in research regarding interventions, stigma, and coping mechanisms.
Main Methods:
- Systematic literature search of Medline, ISI Web of Knowledge, Google Scholar, and AASLD website until January 2012.
- Content categorized into HRQOL, mental health, and psychosocial issues (stigma, coping).
Main Results:
- Increasing CHBV severity and cirrhosis negatively impact HRQOL; treatment and psycho-education show improvement.
- Mood disorders may be more frequent in CHBV patients; alcohol and low social support are detrimental.
- CHBV patients generally fare better in HRQOL and mental health than hepatitis C (HCV) patients; stigma requires further investigation.
Conclusions:
- HRQOL and mental health are significantly affected in CHBV, especially in severe cases.
- Intervention studies for psychosocial problems in CHBV are limited.
- Further research is needed on stigma, coping, and psychosomatic disorders in CHBV.
Abstract:
Psychosocial issues and health-related quality of life (HRQOL) are important components of care in patients diagnosed with chronic hepatitis B (CHBV). In this review, we searched Medline, ISI Web of Knowledge, Google Scholar and the American Association for the Study of Liver Diseases (AASLD) website (until January 2012) using relevant terms and we categorized the retrieved content into three areas: HRQOL, mental health, and psychosocial issues such as stigma and coping. Increasing severity of CHBV leads to a decline in HRQOL. Cirrhosis worsens HRQOL, whereas treatment and psycho-education improves it. Frequency of mood disorders seems to be increased in patients with CHBV, although not all studies have shown this trend. Some factors such as alcohol consumption and low social support negatively impact patients' mental health. Those with CHBV generally have better HRQOL and mental health than their hepatitis C (HCV) counterparts. Patients with psychiatric disorders, particularly those with prolonged institutionalization, have a generally higher risk of acquiring CHBV infection compared to the general population. Robust studies regarding the stigma in patients with CHBV are lacking, although some studies have suggested a higher degree of perceived stigma in these patients. HRQOL and mental health are significantly affected in CHBV patients, particularly in those with more severe forms of the disease. There are few studies that addressed the effects of intervention in CHBV patients with psychosocial problems. Other subjects necessitating additional research include stigma, coping mechanisms, and other less common, yet important psychosomatic disorders.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Viral Hepatitis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
